Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Dalbavancin HCL (CDM PH018737) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 3, 2026 , from http://ppman.hank.ai/transparency/procedure/PH018737/by-state?code_type=CDM
“Dalbavancin HCL (CDM PH018737) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/PH018737/by-state?code_type=CDM. Accessed
November 3, 2026 .
“Dalbavancin HCL (CDM PH018737) by State,” HANK Price Transparency ,
accessed November 3, 2026 ,
http://ppman.hank.ai/transparency/procedure/PH018737/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
PH018737 — Dalbavancin Hcl
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$8,540
National median
$8,540 – $8,540
IQR (p25 – p75)
3
hospitals filing
2
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for PH018737 (CDM), with interquartile range
State Median p25 p75
LA $8,540 $8,540 $8,540
TX $8,540 $8,540 $8,540